SCANDMEDICAL SOLDK-040 Financials

You should never invest in SCANDMEDICAL SOLDK-040 without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of SCANDMEDICAL Stock, because this is throwing your money away. Analyzing the key information contained in SCANDMEDICAL SOLDK-040's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

SCANDMEDICAL SOLDK-040's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. SCANDMEDICAL SOLDK-040 volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.

The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on SCANDMEDICAL SOLDK 040 correlated with the market. If Beta is less than 0 SCANDMEDICAL SOLDK-040 generally moves in the opposite direction as compared to the market. If SCANDMEDICAL SOLDK-040 Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one SCANDMEDICAL SOLDK 040 is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of SCANDMEDICAL SOLDK-040 is generally in the same direction as the market. If Beta > 1 SCANDMEDICAL SOLDK-040 moves generally in the same direction as, but more than the movement of the benchmark.